News

The article highlights how Nuage is deploying a suite of proprietary¡y biophysics tools that ‘capture’ intrinsically-disordered proteins in a secondary-structured …

Dr. Stuart Hughes has broad R&D leadership experience in a range of settings, having worked in drug discovery across multiple therapeutic areas. Vanessa Malier is a board member and advisor to several biotechs, venture capital and private equity firms.

Protein droplets reveal new ways to inhibit transcription factors in an aggressive form of prostate cancer

The seed financing aims to validate that the know-how developed on AR can be applied to other targets and has a broad applicability